Gene:
CXCL3
chemokine (C-X-C motif) ligand 3

PharmGKB contains no dosing guidelines for this . To report known genotype-based dosing guidelines, or if you are interested in developing guidelines, click here.

PharmGKB has no annotated drug labels with pharmacogenomic information for this . If you know of a drug label with PGx, send us a message.

PharmGKB contains no Clinical Variants that meet the highest level of criteria.

Disclaimer: The PharmGKB's clinical annotations reflect expert consensus based on clinical evidence and peer-reviewed literature available at the time they are written and are intended only to assist clinicians in decision-making and to identify questions for further research. New evidence may have emerged since the time an annotation was submitted to the PharmGKB. The annotations are limited in scope and are not applicable to interventions or diseases that are not specifically identified.

The annotations do not account for individual variations among patients, and cannot be considered inclusive of all proper methods of care or exclusive of other treatments. It remains the responsibility of the health-care provider to determine the best course of treatment for a patient. Adherence to any guideline is voluntary, with the ultimate determination regarding its application to be made solely by the clinician and the patient. PharmGKB assumes no responsibility for any injury or damage to persons or property arising out of or related to any use of the PharmGKB clinical annotations, or for any errors or omissions.

? = Mouse-over for quick help

This is a non-comprehensive list of genetic tests with pharmacogenetics relevance, typically submitted by the manufacturer and manually curated by PharmGKB. The information listed is provided for educational purposes only and does not constitute an endorsement of any listed test or manufacturer.

A more complete listing of genetic tests is found at the Genetic Testing Registry (GTR).

PGx Test Variants Assayed Related Drugs?

Overview

Alternate Names:  GRO3
Alternate Symbols:  CINC-2b; GROg; MIP-2b; SCYB3
PharmGKB Accession Id: PA35052

Details

Cytogenetic Location: chr4 : q13.3 - q13.3
GP mRNA Boundary: chr4 : 74902306 - 74904490
GP Gene Boundary: chr4 : 74899306 - 74914490
Strand: minus
The mRNA boundaries are calculated using the gene's default feature set from NCBI, mapped onto the UCSC Golden Path. PharmGKB sets gene boundaries by expanding the mRNA boundaries by no less than 10,000 bases upstream (5') and 3,000 bases downstream (3') to allow for potential regulatory regions.

LinkOuts

Entrez Gene:
2921
OMIM:
139111
UCSC Genome Browser:
NM_002090
RefSeq RNA:
NM_002090
RefSeq Protein:
NP_002081
RefSeq DNA:
AC_000047
AC_000136
NC_000004
NT_022778
NW_001838914
NW_922162
UniProtKB:
CXCL3_HUMAN (P19876)
Ensembl:
ENSG00000163734
GenAtlas:
CXCL3
GeneCard:
CXCL3
MutDB:
CXCL3
ALFRED:
LO216898I
HuGE:
CXCL3
Comparative Toxicogenomics Database:
2921
ModBase:
P19876
HumanCyc Gene:
HS08922
HGNC:
4604

Common Searches